Hong Seng buys 51% stake in Pantasniaga


In a statement yesterday, Hong Seng said Pantasniaga has the know-how and experience to build test labs for the Covid-19 test screening samples.

PETALING JAYA: Hong Seng Consolidated Bhd, via its wholly-owned subsidiary HS Bio Supplies Sdn Bhd, has acquired 51% stake in Pantasniaga Sdn Bhd, which has been supplying polymerase chain reaction (PCR) test kits for Covid-19.

In a statement yesterday, Hong Seng said Pantasniaga has the know-how and experience to build test labs for the Covid-19 test screening samples.

“HS Bio has been working hard into its foray in the healthcare sector. Through the acquisition of Pantasniaga, HS Bio will be involved in serving the nation to help government agencies procure PCR test kits for Sabah’s Covid-19 outbreak.”

As Pantasniaga has already performed and fulfilled a few supply contracts for Malaysian government agencies, Hong Seng said HS Bio would be continuing its support to procure and supply the PCR test kits with the ongoing outbreak in Malaysia, as well as neighbouring countries.

Pantasniaga has also received letters of offer and secured a supply contract of RM25mil to a Malaysian government agency to curb the immediate crisis in Sabah.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Hong Seng , HS Bio , Pantasniaga

   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In Business News

Slack’s CEO is back in the passenger seat after Salesforce deal
Natural gas to contribute RM400mil to public finances over next decade
SCIB units secure EPCC contracts worth RM271mil
Flipkart’s digital payments firm PhonePe to raise US$700mil from existing investors
Astro posts RM164.5mil profit in Q3�
Bursa rallies with over 900 counters in positive zone
More US-listed Chinese firms seen seeking backup listings
Cagamas prices RM2bil debt notes 30-45 bps above MGS, MGII
Corporate Singapore faces crunch time in rare clash with activist funds
Grab 'in a position to acquire' after Gojek merger report

Stories You'll Enjoy